We are Sorry, This Page doesn't Exist
Wednesday’s Vital Data: Valeant Pharmaceuticals Intl Inc (VRX), Walt Disney Co (DIS) and Citigroup Inc (C)
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Valeant (VRX) and Disney (.....»»
Valeant Pharmaceuticals Intl Inc Has New Name But Same Problems
InvestorPlace - Stock Market News, Stock Advic.....»»
Valeant Pharmaceuticals Intl Inc Shares Sink on Psoriasis Treatment Rejection by FDA
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Valean.....»»
Valeant Posts Q1 Earnings Beat, Announces Name Change To Bausch Health
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares were surging nearly 14 percent after the open Tuesday after the company reported first-quarter results and announced a name change to Bausch Health Companies Inc. read more.....»»
Valeant Posts Q1 Earnings Beat, Announces Name Change To Bausch Health
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares were.....»»
Why Valeant Pharmaceuticals International Stock Is Moving Higher Today
The pace of Valeant's turnaround may be picking up......»»
Bausch Health Insiders Are Stepping Up Their Stock Buys
Three executives at the former Valeant Pharmaceuticals have bought $5.1 million in shares so far this year......»»
Insider Weekends: 3 Insiders Of The Company Formerly Known As Valeant Pharmaceuticals Buy Stock
Insider Weekends: 3 Insiders Of The Company Formerly Known As Valeant Pharmaceuticals Buy Stock.....»»
Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends
Incyte acquires Escient Pharmaceuticals for $750 million, bolstering its pipeline. Cantor Fitzgerald initiates coverage with a Neutral rating, citing undervaluation concerns despite strong cash flow. Latest Ratings for INCY DateFirmActio.....»»
Why Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors" Radars Today
On Wednesday, key U.S. stock indexes closed lower, as the Dow Jones I.....»»
Pieris stock rockets on record volume after Genentech collaboration valued at up to $1.4 billion
Shares of Pieris Pharmaceuticals Inc. rocketed 57.3% on massive volume in afternoon trading Tuesday, after the Boston-based biotechnology company announced a respiratory and ophthalmology collaboration with Roche Holding AG's .....»»
What"s Going On With Pieris Pharmaceuticals Stock Today?
Pieris Pharmaceuticals Inc (NASDAQ: PIRS) shares are trading higher by 57% at $2.91 after the company announced a respiratory and ophthalmology collaboration with Genentech. read more.....»»
Anebulo Pharmaceuticals started at buy with $15 stock price target at Benchmark
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Xeris Pharmaceuticals to acquire Strongbridge Biopharma for $267M in stock, CVRs
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Xeris Pharmaceuticals to acquire Strongbridge in stock, CVR transaction
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pieris Pharmaceuticals files to sell 3.58M shares of common stock for holders
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Armata Pharmaceuticals files to sell 12.3M shares of common stock for holders
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Eloxx Pharmaceuticals announces common stock offering, no amount given
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Galmed Pharmaceuticals stock price target cut to $6 from $10 at Maxim Group
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Citius Pharmaceuticals files to sell 25.0M shares of common stock for holders
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»